Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 10:48 PM
Study NCT ID:
NCT00679367
Status:
COMPLETED
Last Update Posted:
2017-02-20
First Post:
2008-05-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
Sponsor:
Boston Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05
Start Date Type:
None
Primary Completion Date:
2015-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-14
First Submit QC Date:
None
Study First Post Date:
2008-05-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-09
Results First Submit QC Date:
None
Results First Post Date:
2017-02-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-28
Last Update Post Date:
2017-02-20
Last Update Post Date Type:
ACTUAL